LUCD: Lucid Diagnostics Inc Company Profile & Statistics

About

Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK.

Info & Links

CEO

Lishan Aklog

Headquarters

360 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY 10017, UNITED STATES

Auditor

Marcum LLP

Share holders

256

Employees

Lucid Diagnostics Inc Statistics

Valuation Measures

Market Capitalization²

45.06M

Enterprise Value

40.77M

Enterprise Value/EBITDA(ttm)

-0.94

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

11.06

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-53.67%

Operating Margin(ttm)

-855.46%

Profit Margin(ttm)

-1258.36%

Return on Equity(ttm)

Return on Invested Capital(ttm)

115.35%

Return on Assets(ttm)

-123.54%

Income Statement

Revenue(ttm)

4.19M

Revenue Per Share(ttm)

0.08

Gross Profit(ttm)

-2.22M

EBITDA(ttm)³

-43.56M

Net Income Available to Common(ttm)

-52.31M

Diluted EPS(ttm)

-1.14

Share Statistics

Beta (5Y Monthly)

1.42

52-Week Change

-50.69%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

55.50M

Dividend Yield

0.00%

Float⁴

54.12M

% Held by Insiders

8.80%

% Held by Institutions

74.01%

Balance Sheet

Total Cash(mrq)

14.49M

Total Cash Per Share(mrq)

0.26

Total Debt(mrq)

10.20M

Total Debt/Equity(mrq)

160.93%

Current Ratio(mrq)

1.18%

Quick Ratio(mrq)

1.14%

Book Value Per Share(mrq)

0.12

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.68

Free Cash Flow(ytd)

-34.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

LUCD

Lucid Diagnostics Inc

Lucid Diagnostics Inc Profile